smallpox vaccine to share them during the Monkeypox outbreaks. The aims to do so would be to offer equitable access to vaccines during another pandemic.
Meanwhile, drugmaker Bavarian Nordic said US and European regulators have approved the use of Jynneos vaccine doses made at the company's plant in Denmark as global efforts to tackle the monkeypox outbreak pick up pace.
The US Food and Drug Administration's approval for the fill-and-finish plant will lead to the availability of an additional 786,000 doses of vaccine in the United States, Health and Human Services Secretary Xavier Becerra said in a statement. "Additional doses manufactured at this plant can help address the need for this vaccine moving forward," the FDA said.
Bavarian has received orders for millions of doses from across the globe, including nearly 7 million vaccine doses this year and next to the United States.